Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy and VRE-Colonized Subjects

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 25, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Vancomycin-Resistant Enterococcal Colonization
Interventions
BIOLOGICAL

VRELysin™

A cocktail of lytic Enterococcus-specific bacteriophages orally administered with sodium bicarbonate solution

OTHER

Placebo

Placebo orally administered with sodium bicarbonate solution

Trial Locations (1)

15213

RECRUITING

UPMC Presbyterian, Pittsburgh

All Listed Sponsors
lead

Intralytix, Inc.

INDUSTRY